The human and canine TERT promoters function equivalently in human and canine cells

M L Arendt; L Nasir; I M Morgan

doi:10.1111/j.1476-5829.2010.00227.x

The human and canine TERT promoters function equivalently in human and canine cells

M L Arendt, L Nasir, I M Morgan

1 Citation (Scopus)

Abstract

Telomerase targeted cancer gene therapy is being exploited for treatment of human cancer. The high incidence and many comparative aspects of human and canine cancer and the compliance and dedication of dog owners to treat cancer makes the canine pet population a good clinical model for investigating and developing new cancer therapeutics. Here, we report that the human telomerase promoter operates in canine cells, suggesting that human telomerase promoter-driven cancer therapy can be used to treat cancer in canines. Therefore, the canine pet population can act as a clinical model for new drug development based on telomerase therapeutics.

Original language	English
Journal	Veterinary and Comparative Oncology
Volume	8
Issue number	4
Pages (from-to)	310-6
Number of pages	7
ISSN	1476-5810
DOIs	https://doi.org/10.1111/j.1476-5829.2010.00227.x
Publication status	Published - Dec 2010

Keywords

Animals
Cell Line
Dogs
Gene Expression Regulation/physiology
Humans
Plasmids
Promoter Regions, Genetic/genetics
Telomerase/genetics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1476-5829.2010.00227.x

Cite this

@article{43e9f94f21ea42b9b276bcd3f474cc37,

title = "The human and canine TERT promoters function equivalently in human and canine cells",

abstract = "Telomerase targeted cancer gene therapy is being exploited for treatment of human cancer. The high incidence and many comparative aspects of human and canine cancer and the compliance and dedication of dog owners to treat cancer makes the canine pet population a good clinical model for investigating and developing new cancer therapeutics. Here, we report that the human telomerase promoter operates in canine cells, suggesting that human telomerase promoter-driven cancer therapy can be used to treat cancer in canines. Therefore, the canine pet population can act as a clinical model for new drug development based on telomerase therapeutics.",

keywords = "Animals, Cell Line, Dogs, Gene Expression Regulation/physiology, Humans, Plasmids, Promoter Regions, Genetic/genetics, Telomerase/genetics",

author = "Arendt, {M L} and L Nasir and Morgan, {I M}",

note = "{\textcopyright} 2010 Blackwell Publishing Ltd.",

year = "2010",

month = dec,

doi = "10.1111/j.1476-5829.2010.00227.x",

language = "English",

volume = "8",

pages = "310--6",

journal = "Veterinary and Comparative Oncology",

issn = "1476-5810",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - The human and canine TERT promoters function equivalently in human and canine cells

AU - Arendt, M L

AU - Nasir, L

AU - Morgan, I M

PY - 2010/12

Y1 - 2010/12

N2 - Telomerase targeted cancer gene therapy is being exploited for treatment of human cancer. The high incidence and many comparative aspects of human and canine cancer and the compliance and dedication of dog owners to treat cancer makes the canine pet population a good clinical model for investigating and developing new cancer therapeutics. Here, we report that the human telomerase promoter operates in canine cells, suggesting that human telomerase promoter-driven cancer therapy can be used to treat cancer in canines. Therefore, the canine pet population can act as a clinical model for new drug development based on telomerase therapeutics.

AB - Telomerase targeted cancer gene therapy is being exploited for treatment of human cancer. The high incidence and many comparative aspects of human and canine cancer and the compliance and dedication of dog owners to treat cancer makes the canine pet population a good clinical model for investigating and developing new cancer therapeutics. Here, we report that the human telomerase promoter operates in canine cells, suggesting that human telomerase promoter-driven cancer therapy can be used to treat cancer in canines. Therefore, the canine pet population can act as a clinical model for new drug development based on telomerase therapeutics.

KW - Animals

KW - Cell Line

KW - Dogs

KW - Gene Expression Regulation/physiology

KW - Humans

KW - Plasmids

KW - Promoter Regions, Genetic/genetics

KW - Telomerase/genetics

U2 - 10.1111/j.1476-5829.2010.00227.x

DO - 10.1111/j.1476-5829.2010.00227.x

M3 - Journal article

C2 - 21062413

SN - 1476-5810

VL - 8

SP - 310

EP - 316

JO - Veterinary and Comparative Oncology

JF - Veterinary and Comparative Oncology

IS - 4

ER -

The human and canine TERT promoters function equivalently in human and canine cells

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this